NASDAQ:VXRT - Vaxart Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$3.19 +0.39 (+13.93 %)
(As of 09/24/2018 06:00 AM ET)
Previous Close$3.19
Today's Range$2.71 - $3.19
52-Week Range$2.37 - $11.88
Volume50,423 shs
Average Volume21,490 shs
Market Capitalization$22.78 million
P/E RatioN/A
Dividend YieldN/A
Beta0.06
Vaxart logoVaxart, Inc., a clinical-stage company, focuses on developing oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company's platform delivers various recombinant protein antigens, such as those used in influenza, hepatitis B, and human papilloma virus (HPV) vaccines, as well as other recombinant vaccines. Its development programs include oral tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus, as well as a therapeutic vaccine for HPV. The company is headquartered in South San Francisco, California.

Receive VXRT News and Ratings via Email

Sign-up to receive the latest news and ratings for VXRT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:VXRT
CUSIPN/A
Phone650-550-3500

Debt

Debt-to-Equity Ratio0.12
Current Ratio2.90
Quick Ratio2.90

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$8.90 million
Price / Sales2.56
Cash FlowN/A
Price / CashN/A
Book Value($11.02) per share
Price / Book-0.29

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-3,400,000.00
Net Margins-317.57%
Return on Equity-195.55%
Return on Assets-39.01%

Miscellaneous

Employees16
Outstanding Shares7,140,000
Market Cap$22.78 million

Vaxart (NASDAQ:VXRT) Frequently Asked Questions

What is Vaxart's stock symbol?

Vaxart trades on the NASDAQ under the ticker symbol "VXRT."

When did Vaxart's stock split? How did Vaxart's stock split work?

Shares of Vaxart reverse split before market open on Wednesday, February 14th 2018. The 1-11 reverse split was announced on Tuesday, February 13th 2018. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 13th 2018. An investor that had 100 shares of Vaxart stock prior to the reverse split would have 9 shares after the split.

How were Vaxart's earnings last quarter?

Vaxart Inc (NASDAQ:VXRT) released its quarterly earnings results on Thursday, August, 9th. The biotechnology company reported ($1.02) earnings per share for the quarter. The biotechnology company earned $0.61 million during the quarter. Vaxart had a negative return on equity of 195.55% and a negative net margin of 317.57%. View Vaxart's Earnings History.

When is Vaxart's next earnings date?

Vaxart is scheduled to release their next quarterly earnings announcement on Thursday, November, 1st 2018. View Earnings Estimates for Vaxart.

What is the consensus analysts' recommendation for Vaxart?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vaxart in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Vaxart.

Who are some of Vaxart's key competitors?

Who are Vaxart's key executives?

Vaxart's management team includes the folowing people:
  • Dr. Wouter W. Latour M.B.A., M.D., MBA, Pres, CEO & Director (Age 60)
  • Dr. Sean N. Tucker, Founder & Chief Scientific Officer (Age 50)
  • Mr. John M. Harland M.B.A., CPA, CFO & Sec. (Age 66)
  • Mr. Brant Biehn, Sr. VP of Commercial Operations
  • Dr. David N. Taylor, Chief Medical Officer (Age 69)

Who are Vaxart's major shareholders?

Vaxart's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (3.00%). View Institutional Ownership Trends for Vaxart.

Which institutional investors are buying Vaxart stock?

VXRT stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC. View Insider Buying and Selling for Vaxart.

How do I buy shares of Vaxart?

Shares of VXRT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Vaxart's stock price today?

One share of VXRT stock can currently be purchased for approximately $3.19.

How big of a company is Vaxart?

Vaxart has a market capitalization of $22.78 million and generates $8.90 million in revenue each year. Vaxart employs 16 workers across the globe.

What is Vaxart's official website?

The official website for Vaxart is http://www.vaxart.com.

How can I contact Vaxart?

Vaxart's mailing address is 290 Utah Ave. Suite 200, South San Francisco CA, 94080. The biotechnology company can be reached via phone at 650-550-3500 or via email at [email protected]


MarketBeat Community Rating for Vaxart (NASDAQ VXRT)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  134 (Vote Outperform)
Underperform Votes:  112 (Vote Underperform)
Total Votes:  246
MarketBeat's community ratings are surveys of what our community members think about Vaxart and other stocks. Vote "Outperform" if you believe VXRT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VXRT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel